AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

Funding Agency:
Health Resources and Services Administration

This notice solicits applications for the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. 

ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance). HRSA will base ADAP awards upon applicants’ ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.

HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of publication of this NOFO, there are no ADAP waiting lists. HRSA continues to provide funding under this initiative to maintain infrastructure in those states/territories that had previously imposed waiting lists, and to ensure that no new waiting lists are established. States/territories that have not reported an existing waiting list to HRSA must do so immediately and use funding awarded under this NOFO to remove clients from the waiting list. 

Applicants are encouraged to consider how their proposed activities with the ADAP ERF funding support HRSA’s emphasis on innovation, collaboration, impact, and effectiveness.

Multiple applications from an organization are not allowable.

  • Duke Internal Deadline: August 1, 2018
  • Sponsor Deadline: October 25, 2018

If the internal deadline has passed and you are interested in this opportunity, please email Anastasia Maddox at to find out if it is still open.

Agency Website

Areas of Interest

Eligibility Requirements

Eligible applicants are limited to RWHAP Part B states/territories that reported to HRSA a new ADAP waiting list or who have used the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2018. 

All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the above requirement.

States/territories that did not report to HRSA a new ADAP waiting list or use the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2018 are not eligible to apply. 

If you answer NO to the questions below, you are not eligible to apply.

a) Eligibility for ADAP ERF Funding
i. Did you report to HRSA an ADAP waiting list between January 2011 and July 2018? (Yes/No)
ii. Did you use ADAP ERF funds to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2018? (Yes/No)



Amount Description

HRSA expects approximately $65,000,000 to be available to fund up to 15 recipients. You may apply for a ceiling amount of up to $11,000,000 total cost (includes both direct and indirect, facilities and administrative costs) per year. The actual amount available will not be determined until enactment of the final FY 2019 federal appropriation. This program notice is subject to the appropriation of funds, and is a contingency action taken to ensure that, should funds become available for this purpose, HRSA can process applications and award funds in a timely manner. The period of performance is April 1, 2019 through March 31, 2020 (1 year).

Funding Type



Medical - Clinical Science

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

* A letter of support from dean or chair - 1 to 1.5 pages
* Project summary - 2 to 4 pages
* CV or Biosketch of project leader

Please submit internal materials through My Research Proposal. (Code ILN)

Instructions for setting up your account and uploading internal applications can be found here:

Internal Deadline

August 1, 2018

External Deadline

October 25, 2018